Mary T Barra, the Chair & CEO of $GM, sold 372,024 shares of the company on 08-28-2025 for an estimated $21,666,677. We received data on the trade from a recent SEC filing. This was a sale of approximately 40.3% of their shares of this class of stock. Following this trade, they now own 552,238 shares of this class of $GM stock.
$GM Insider Trading Activity
$GM insiders have traded $GM stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $GM stock by insiders over the last 6 months:
- MARY T BARRA (Chair & CEO) has made 0 purchases and 4 sales selling 994,863 shares for an estimated $57,931,158.
- CHRISTOPHER HATTO (Vice President & CAO) has made 0 purchases and 3 sales selling 51,471 shares for an estimated $2,893,406.
- RORY HARVEY (Executive Vice President) has made 0 purchases and 3 sales selling 23,977 shares for an estimated $1,271,032.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GM Hedge Fund Activity
We have seen 509 institutional investors add shares of $GM stock to their portfolio, and 833 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 11,418,367 shares (+11.5%) to their portfolio in Q2 2025, for an estimated $561,897,840
- VIKING GLOBAL INVESTORS LP added 5,830,050 shares (+81.1%) to their portfolio in Q2 2025, for an estimated $286,896,760
- BLACKROCK, INC. removed 5,822,259 shares (-6.3%) from their portfolio in Q2 2025, for an estimated $286,513,365
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 4,745,608 shares (-50.2%) from their portfolio in Q2 2025, for an estimated $233,531,369
- HARRIS ASSOCIATES L P removed 4,365,899 shares (-14.7%) from their portfolio in Q2 2025, for an estimated $214,845,889
- QUBE RESEARCH & TECHNOLOGIES LTD added 3,662,650 shares (+inf%) to their portfolio in Q2 2025, for an estimated $180,239,006
- JACOBS LEVY EQUITY MANAGEMENT, INC added 3,466,713 shares (+560.9%) to their portfolio in Q2 2025, for an estimated $170,596,946
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$GM Congressional Stock Trading
Members of Congress have traded $GM stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GM stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$GM Analyst Ratings
Wall Street analysts have issued reports on $GM in the last several months. We have seen 8 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Wedbush issued a "Outperform" rating on 08/19/2025
- B of A Securities issued a "Buy" rating on 07/23/2025
- Citigroup issued a "Buy" rating on 07/23/2025
- Wells Fargo issued a "Underweight" rating on 07/23/2025
- Benchmark issued a "Buy" rating on 07/21/2025
- JP Morgan issued a "Overweight" rating on 07/21/2025
- Mizuho issued a "Outperform" rating on 05/16/2025
To track analyst ratings and price targets for $GM, check out Quiver Quantitative's $GM forecast page.
$GM Price Targets
Multiple analysts have issued price targets for $GM recently. We have seen 13 analysts offer price targets for $GM in the last 6 months, with a median target of $58.0.
Here are some recent targets:
- Daniel Ives from Wedbush set a target price of $65.0 on 08/19/2025
- John Murphy from B of A Securities set a target price of $62.0 on 07/23/2025
- Michael Ward from Citigroup set a target price of $61.0 on 07/23/2025
- Colin Langan from Wells Fargo set a target price of $38.0 on 07/23/2025
- Mickey Legg from Benchmark set a target price of $65.0 on 07/21/2025
- Ryan Brinkman from JP Morgan set a target price of $60.0 on 07/21/2025
- Dan Levy from Barclays set a target price of $55.0 on 07/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
